• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MELODY TRANSCATHETER PULMONARY VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELI

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MELODY TRANSCATHETER PULMONARY VALVE; PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELI Back to Search Results
Model Number PB1018
Device Problem Gradient Increase (1270)
Patient Problems High Blood Pressure/ Hypertension (1908); Low Cardiac Output (2501); Cardiovascular Insufficiency (4445); Valvular Insufficiency/ Regurgitation (4449); Pulmonary Valve Insufficiency/ Regurgitation (4452); Swelling/ Edema (4577)
Event Date 02/28/2022
Event Type  Injury  
Manufacturer Narrative
Product analysis: the device remains implanted, therefore no product analysis can be performed.Conclusion: without the return of the product, no definitive conclusion can be made regarding the clinical observation.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that approximately eight years and four months following implant of this transcatheter bioprosthetic pulmonary valve into a patient with a previously implanted homograft (manufacturer unknown) for tetralogy of fallot (tof), the patient reported leg edema, moderate reduced left ventricle function, right ventricle (rv) dilation and reduced systolic function.It was reported that the valve had trivial insufficiency.Approximately a month and a half later, a diagnostic catheterization was performed again revealing post-capillary pulmonary hypertension , rv to pulmonary artery (pa) gradient of 45mmhg with nearly systemic rv pressure, confirmation of reduced left ventricle function, and no relevant atrial shunt.The rv pressure measured 90 mmhg, the pa pressure measured 58 mmhg and the femoral artery pressure measured 100 mmhg.Approximately eight years and seven months following the initial implant of this valve, the valve was re-dilated using a 24 mm non-medtronic balloon.The valve was then replaced with a second transcatheter bioprosthetic pulmonary valve.The replacement valve was post-dilated using a 24 mm non-medtronic balloon.The rv to pa pressure following the replacement valve was 8 mmhg.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MELODY TRANSCATHETER PULMONARY VALVE
Type of Device
PULMONARY VALVE PROSTHESIS PERCUTANEOUSLY DELI
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key13636651
MDR Text Key286362223
Report Number2025587-2022-00555
Device Sequence Number1
Product Code NPV
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P140017
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 03/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/21/2015
Device Model NumberPB1018
Device Catalogue NumberPB1018
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/28/2022
Initial Date FDA Received03/01/2022
Date Device Manufactured06/05/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age51 YR
Patient SexMale
Patient Weight120 KG
-
-